By proceeding, you agree to our Terms of Use and Privacy Policy.
Andrew Haak is Assistant Professor at Mayo Clinic
Talks About #Biotechnology #DrugDiscovery
Preferred Locations #NorthAmerica
With two approved therapeutics and the field working to develop the next generation of IPF drugs, the opportunity to become the undisputed, most effective, and disease-modifying agent on the market has never been greater.